|
|
rna processing
|
GO:0006396 |
255 |
0.571
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.210
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
90 |
0.171
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.153
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.101
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.094
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.084
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.079
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.078
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.075
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.062
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.061
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.060
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.058
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.053
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.051
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.048
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.047
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.046
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.042
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.041
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.038
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.037
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.035
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.034
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.033
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.033
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.033
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.032
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.031
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.031
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.031
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.030
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.030
|
|
|
|
regulation of mitosis
|
GO:0007088 |
63 |
0.030
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.029
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.028
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.028
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.028
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.028
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.027
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.027
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.027
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.027
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.027
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.026
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.025
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.024
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.024
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.024
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.023
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.023
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.022
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.022
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.022
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.022
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.022
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.022
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
17 |
0.021
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
26 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.021
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.021
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.021
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.021
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.021
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.021
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.021
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.021
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.020
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.020
|
|
|
|
positive regulation of response to alcohol
|
GO:1901421 |
3 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.020
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.019
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.019
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.019
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.019
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.019
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.019
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.018
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.018
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.018
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.018
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.018
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.018
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.018
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.017
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.017
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.017
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.017
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.016
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.016
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.016
|
|
|
|
regulation of cell maturation
|
GO:1903429 |
3 |
0.016
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.016
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.015
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.015
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.015
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.015
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.015
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.015
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.015
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.015
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.015
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.015
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.015
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.015
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.015
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.015
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.015
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.015
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.015
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.014
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.014
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.014
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.014
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.014
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
54 |
0.014
|
|
|
|
regulation of oocyte development
|
GO:0060281 |
1 |
0.014
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.014
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.014
|
|
|
|
rna transport
|
GO:0050658 |
39 |
0.014
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.014
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.014
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.014
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.013
|
|
|
|
chromosome separation
|
GO:0051304 |
23 |
0.013
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.013
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.013
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.013
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.013
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.013
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.013
|
|
|
|
negative regulation of dephosphorylation
|
GO:0035305 |
63 |
0.013
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.013
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.013
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.013
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.012
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.012
|
|
|
|
establishment of nucleus localization
|
GO:0040023 |
1 |
0.012
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.012
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.012
|
|
|
|
negative regulation of phosphatase activity
|
GO:0010923 |
61 |
0.012
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
2 |
0.012
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.012
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.012
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.012
|
|
|
|
golgi organization
|
GO:0007030 |
38 |
0.012
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.011
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.011
|
|
|
|
protein complex disassembly
|
GO:0043241 |
52 |
0.011
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.011
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.011
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.011
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.011
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.011
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.011
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
5 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.011
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.011
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.011
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.011
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.011
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.011
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.011
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.011
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.011
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.011
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.011
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.010
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.010
|
|
|
|
spindle elongation
|
GO:0051231 |
4 |
0.010
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.010
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.010
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.010
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.010
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.010
|
|